Healthcare & Biotech
ParcelBio
Elevated mRNA for transformative medicines.
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The…
- Therapeutics
- Gene Therapy
- Synthetic Biology
- Website
- parcelbio.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 2-10 people
- Founded
- 2024
- Demo
- Demo only
Similar companies
Kopra BioGenetically engineered viruses that teach your immune system to kill…
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines
Eugit TherapeuticsEnabling Tissue Targeting of Therapies
Rejuvenation Technologies Inc.mRNA therapeutics to extend healthspan entering clinical trials
Humane GenomicsA platform to make artificial viruses as cancer therapeutics.
Uncommon TherapeuticsA Disease Focused Biotech, Building Multiple Billion Dollar Drugs
FinalDoseProgrammable DNA drug destroying all cancers, unlocking 80% of targets
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme